About 300 reports

Global Mycoplasma Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

140 pages • By Occams

The global mycoplasma testing market is expected to grow with the CAGR of approximately 13.4% during the forecast period (2016-2023). The mycoplasma market is primarily driven due to various factors such as increasing funding for life science researches, increasing number of biotechnology & pharmaceutical firms, increasing demand for PCR based...

3545 3900 3014
May 2017

Global Regenerative Medicine Market Analysis & Forecast to 2021; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

682 pages • By Kelly Scientific Publications

This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. Kelly Scientific analysis indicates that the global regenerative medicine...

4455 4900 3786
May 2017

The 2018-2023 World Outlook for RNA Interference (RNAi) Technologies

296 pages • By ICON Group

This study covers the world outlook for RNA interference (RNAi) technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Regenerative Medicine Ceramics

292 pages • By ICON Group

This study covers the world outlook for regenerative medicine ceramics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Stem Cell Treatments

293 pages • By ICON Group

This study covers the world outlook for stem cell treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Cell Line Development

293 pages • By ICON Group

This study covers the world outlook for cell line development across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe....

905 995 769
Apr 2017

The 2018-2023 World Outlook for Tissue Engineering and Cell Therapies

296 pages • By ICON Group

This study covers the world outlook for tissue engineering and cell therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Mesenchymal Stem Cells (MSC)

293 pages • By ICON Group

This study covers the world outlook for mesenchymal stem cells (MSC) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Human Embryonic Stem Cell (hESC) Research

302 pages • By ICON Group

This study covers the world outlook for human embryonic stem cell (hESC) research across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region,...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Cell Cultures

292 pages • By ICON Group

This study covers the world outlook for cell cultures across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Gene Therapy

292 pages • By ICON Group

This study covers the world outlook for gene therapy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Adult Stem Cell Research

292 pages • By ICON Group

This study covers the world outlook for adult stem cell research across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe....

905 995 769
Apr 2017

The 2018-2023 World Outlook for Stem Cell Therapies

292 pages • By ICON Group

This study covers the world outlook for stem cell therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Stem Cell Research

293 pages • By ICON Group

This study covers the world outlook for stem cell research across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Brachytherapy Devices

292 pages • By ICON Group

This study covers the world outlook for brachytherapy devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe....

905 995 769
Apr 2017

The 2018-2023 World Outlook for Stem Cell Technologies

293 pages • By ICON Group

This study covers the world outlook for stem cell technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe....

905 995 769
Apr 2017

The 2018-2023 World Outlook for Stem Cells

292 pages • By ICON Group

This study covers the world outlook for stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Umbilical Cord Blood Stem Cells

293 pages • By ICON Group

This study covers the world outlook for umbilical cord blood stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the...

905 995 769
Apr 2017

The 2018-2023 World Outlook for Stem Cell Services

293 pages • By ICON Group

This study covers the world outlook for stem cell services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

905 995 769
Apr 2017

Asia Pacific Stem Cell Market Forecast 2017-2025

65 pages • By Inkwood Research

KEY FINDINGS The Asia Pacific Stem cell market is estimated at $10319 million in the year 2016 and expected to reach $83147 million in the year 2025 at a CAGR of 26.23% during the forecast period 2017-2025.The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The government’s subsidy and...

1125 1238 956
Apr 2017

Europe Stem Cell Market Forecast 2017-2025

65 pages • By Inkwood Research

KEY FINDINGS The Asia Pacific Stem cell market is estimated at $10319 million in the year 2016 and expected to reach $83147 million in the year 2025 at a CAGR of 26.23% during the forecast period 2017-2025.The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The government’s subsidy and...

1125 1238 956
Apr 2017

North America Stem Cell Market Forecast 2017-2025

69 pages • By Inkwood Research

KEY FINDINGS The North America Stem cell market is estimated at $18179 million in the year 2016 and expected to reach $140326 million in the year 2025 at a CAGR of 25.69% during the forecast period 2017-2025. The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The government’s subsidy...

1125 1238 956
Apr 2017

Natural Killer Cells Therapies- Competitive Landscape,Technology and Pipeline Analysis, 2017

207 pages • By Delve Insight

DelveInsight’s report, “Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017”, emphasizes on the currently active NK cell therapy products and NK cell augmenters in research and development. The report covers 20+ companies, which are active in this field with 40+ products and many different...

2227 2450 1893
Apr 2017

China Interferon Industry Report, 2016-2021

82 pages • By Research In China

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-? is mainly suitable for curing hepatitis B and hepatitis C, while IFN-? is the mainstream medicine for MS which sees a higher incidence in Europe and America than in Asia, so foreign countries...

2091 2300 1777
Apr 2017

Interferon Beta-1A Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Interferon Beta-1A Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Beta-1A worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Interferon Beta-1A by countries, and also find out sales forecast...

1000 1100 850
Apr 2017

Imiquimod Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Imiquimod Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Imiquimod worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Imiquimod by countries, and also find out sales forecast until 2021. The research...

1000 1100 850
Apr 2017

Interferon Beta-1B Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Interferon Beta-1B Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Beta-1B worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Interferon Beta-1B by countries, and also find out sales forecast...

1000 1100 850
Apr 2017

Interferon Alfa-2B Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Interferon Alfa-2B Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Interferon Alfa-2B worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Interferon Alfa-2B by countries, and also find out sales forecast...

1000 1100 850
Apr 2017

Sargramostim Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Sargramostim Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Sargramostim worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Sargramostim by countries, and also find out sales forecast until 2021. The...

1000 1100 850
Apr 2017

Filgrastim Sales, Price Analysis, & Sales Forecast - 2017

By Fore Pharma

Fore Pharma has released its new research, Filgrastim Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Filgrastim worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Filgrastim by countries, and also find out sales forecast until 2021. The research...

1000 1100 850
Apr 2017